Volume 7 Supplement M
Acute coronary syndromes: risk stratification and outcomes
1
Acute myocardial infarction: long-term predictive value of thrombolysis in myocardial infarction (TIMI) and global registry of acute coronary events global registry of acute coronary events (GRACE) risk scoresJansen K, Jamart J, Boyasis P, Chenu P, Colles P, Dangoisse V, Domange J, Gabriel L, Guedes A, Marchandise B, Muller A, Paquay J, Perot G, Schroeder E
3
Acute coronary syndrome in patients with non-obstructive coronary artery disease: long-term prognosisRossini R, Musumeci G, Lettieri C, Limbruno U, Molfese M, Capodanno D, Calabria P, Tomasi L, Spatari V, Mihalcsik L, Micheli A, Mantovani P, Fiocca L, Valsecchi O, Guagliumi G, Angiolillo D, Gavazzi A
Be careful! Contrast induced nephropathy is a real issue in daily practice – Part I
10
Sodium bicarbonate plus N-acetylcysteine to prevent contrast induced nephropathy in the setting of primary PCI (BIcarbonato e N-Acetil-cisteina nell’infaRto mIocardico acutO, the BINARIO study)Leone A, De Caterina A, Sciahbasi A, Lioy E, Aurelio A, Basile E, Porto I, Trana C, Burzotta F, Niccoli G, Mazzari M, Mongiardo R, Rebuzzi A, Crea F
Be careful! Contrast induced nephropathy is a real issue in daily practice – Part II
Biomarkers in stable and unstable coronary syndromes
23
ADAMTS13 antigen levels are associated with increasing atherosclerotic burden in patients with stable coronary artery diseasePeace A, Feys H, Mangiacapra F, Conte M, Muller O, Ntalianis A, Puymirat E, Delrue L, Bartunek J, Vanhoorelbeke K, Barbato E
25
Preprocedural elevated white cell count and eosinophilia predict outcome in primary PCIRathod K, Jones D, Guttmann O, Akthar M, Graham A, Sammut E, May S, Behar J, Jain A, Mathur A, Knight C, Wragg A
Biomarkers should be routinely measured after PCI
28
Periprocedural myocardial infarction following stent implantation: comparison between first and second generation DESTandjung K, Basalus M, Muurman E, Louwerenburg J, Van Houwelingen G, Stoel M, De Man F, Jansen H, Huisman J, Linssen G, Droste H, Nienhuis M, von Birgelen C
30
Insights on the mechanisms of periprocedural myocardial infarction after PCIMuschaert X, Slimani A, Jamart J, Chenu P, Dangoisse V, Gabriel L, Domange J, Guedes A, Marchandise B, Mueller A, Perot G, Schroeder E
Coronary perforation and spontaneous dissection: clinical outcome
33
Spontaneous coronary artery dissection: characteristics of a large patient cohort and long-term clinical follow-upPaulo Guzman M, Lennie-Labayru V, Gonzalo N, Escaned J, Hernandez-Antolin R, Jimenez-Quevedo P, Bañuelos De Lucas C, Fernandez Ortiz A, Perez Viscayno M, Dutary J, Bernardo E, Garcia E, Macaya C, Alfonso F
34
Contemporary prevalence and scenarios of coronary perforation during PCIDel Angel Soto J, Del Angel Soto J, Perez-Vizcayno M, Arellano E, Hernandez-Antolin R, Ibanez B, Alfonso F, Jimenez-Quevedo P, Banuelos C, Gonzalo N, Macaya C, Escaned J
35
Replacement of heparin with bivalirudin does not change outcomes after coronary perforation related to PCIRomaguera R, Ben-Dor I, Sardi G, Maluenda G, Laynez A, Mahmoudi M, Hauville C, Torguson R, Xue Z, Suddath W, Satler L, Kent K, Pichard A, Waksman R
DES and endothelial function: a difficult relationship?
37
Endothelial Nitric Oxide Synthase (eNOS) activity and vasomotor dysfunction of coronary arteries after DES: link or chance?Perez De Prado A, Perez-Martinez C, Cuellas C, Gonzalo-Orden J, Diego A, Regueiro M, Martinez B, De Miguel A, Ajenjo J, Altonaga J, Garcia-Iglesias M, Fernandez-Vazquez F
DES registries - Part I
42
Exploring the possible clinical impact of polymer coating in DES technology: clinical outcome of consecutive patients treated by Zotarolimus-eluting Endeavor stent and Zotarolimus-eluting Resolute stentTalarico G, Burzotta F, Trani C, Tommasino A, Coluccia V, Niccoli G, Porto I, Leone A, Mazzari M, Mongiardo R, Schiavoni G, Crea F
44
Off label use of DES with biodegradable polymer at 2 yearsDanzi G, Wijns W, Barbato E, Perisic Z, Koning R, Kala P, Hauptmann K-E, Fath-Ordoubadi F, Carrié D, Chevalier B, Morice M-C, Kornowski R
45
Biolimus A9 drug eluting stents: comparative analyses of pharmacokinetics from three different stent platformsOstojic M, Christians U, Stojkovic S, Beleslin B, Orlic D, Sagic D, Jung R, Clavijo C, Klawitter J, Mangovski L, Milosavljevic B, Debeljacki D, Paunovic D
DES registries - Part II
47
Xience Nile: Prospective Multicenter Egyptian Real World Xience V stent registryRagy H, ElKhadem M, El Guindy H, El Hossary H, El Etriby A, Khamis H, Khashaba A, Seteiha M, Gamal A, Ramsis M, Imam A, AboulMagd A, Abdelfattah Emam M, for the Xience Nile Investigators
50
e-BioMatrix PMS Registry - A post market surveillance registry for the BioMatrix™ drug-eluting stentUrban P, Al-Haddad I, Berland J, Eberli F, Fraser D, Goy J, Hildick - Smith D, Iosseliani D, Kleber F-X, Oldroyd K, Pedrazzini G, Roffi M, Valdes M, Windecker S, Jüni P
Evaluation of thrombus aspiration during primary PCI in STEMI patients
57
Effectiveness of thrombectomy using the export aspiration catheter during primary PCI in STEMIAnthopoulos P, Alexanian I, Pappas L, Moutiris J, Salahas A, Yfantis G, Antonellis I, Karabela G, Flessas N, Michas C, Polydorou A
Functional and clinical impact of successful coronary chronic total occlusion recanalisation
61
Long-term clinical outcome of patients with coronary chronic total occlusion treated with new generation DESChevalier B, Sagic D, Trani C, Tresukosol D, Laanmets P, Lombardi M, Novo Garcia E, Hoffmann S, Schwacke H, Birkemeyer R, Hildick-Smith D, Neskovic A, Stojkovic S, Danzi G
62
Clinical and procedural outcome of PCI for coronary chronic total occlusion with DES: a large single-centre experienceHamid T, Sastry S, Khattar R, Fraser D, El-Omar M, Malik N, Bainbridge A, Khalil M, Clarke B, Rees M, Ordoubadi F
64
A randomised comparison of the efficacy and safety of Zotarolimus-eluting stents vs. Sirolimus-eluting stents for PCI in coronary chronic total occlusions: the catholic total occlusion study (CATOS) trialKim H, Park H, Lee J, Choi Y, Park C, Kim D, Her S, Kim P, Chang K, Chung W, Seung K
65
Efficacy on cardiac function in PCI for coronary chronic total occlusions analysed by echocardiographyTakimura H, Muramatsu T, Tsukahara R, Ito Y, Sakai T, Ishimori H, Hirano K, Nakano M, Yamawaki M, Sasaki S, Araki M, Sakamoto Y, Komatsu I, Takama T
66
Successful recanalisation of chronic total occlusions is associated with increased long term survivalWeerackody R, Jones D, Rathod K, Behar J, Kapur A, Jain A, Knight C, Wragg A, Thompson C, Rothman M, Mathur A, Smith E
67
Successful recanalisation of chronic total occlusions is associated with increased long term survivalWeerackody R, Jones D, Rathod K, Behar J, Kapur A, Jain A, Knight C, Wragg A, Thompson C, Rothman M, Mathur A, Smith E
Is stent thrombosis still an issue?
68
Acute stent thrombosis resulting in STEMI is associated with worse clinical outcomes than STEMI, due to native coronary thrombosisPain T, Behar J, Jones D, Rathod K, Akhtar A, Jain A, Mohiddin S, Knight C, Mathur A, Wragg A
71
Incidence, predictors and outcome of stent thrombosis - up to 8-year follow-up in real-world patients undergoing DES implantationCosta R, Sousa A, Moreira A, Costa Jr J, Maldonado G, Cano M, Feres F, Campos C, Pavanello R, Sousa J
Non-invasive and invasive coronary imaging prior to PCI
80
Radiation dose of 3 diagnosis tests: myocardial perfusion scintigraphy, invasive coronary angiography and cardiac computed tomographySousa P, Gonçalves P, Calé R, Marques H, Santos M, Dias A, Calqueiro J, Ventosa A, Martins T, Silva A, Raposo L, Teles R, Almeida M, Mendes M
PCI for acute coronary syndromes in the elderly
86
Prognosis after PCI in elderly patientsAntonsen L, Jensen L, Thayssen P, Christiansen EH, Junker A, Tilsted H, Kaltoft A, Maeng M, Hansen K, Ravkilde J, Lassen J, Madsen M, Soerensen H, Thuesen L
PCI for bifurcation lesions: clinical results
87
Challenging bifurcation stenting: two-year clinical outcomes after treatment with a new generation DESSerra A, Roguin A, Santarelli A, Santoso T, Marzocchi A, Mauri Ferré F, Martin D, Karavolias G, Trani C, West N, Danzi G
89
Final kissing balloon dilatation in simple stenting of coronary bifurcation lesions: pooled analysis of the BBC ONE study and the Nordic-Baltic bifurcation studiesHolm N, Hildick-Smith D, Niemelä M, Kervinen K, De Belder A, Erglis A, Curzen N, Kumsars I, Oldroyd K, Gunnes P, Stables R, Steigen T, Behan M, Jensen L, überge L, Lassen J, Thuesen L
90
Initial results of BLAST: bifurcation lesion analysis and stenting of thin cap fibroatheroma (TCFA/FA) as measured by VH-intravascular ultrasound - a global multicentre, prospective, randomised studyLefèvre T, Erglis A, Gil R, Legutko J, Thomas M, Brunel P, Gilard M, Darremont O, Bøtker H, von Birgelen C, Marso S, Khashaba A, Guyon P
PCI in multivessel disease patients: determinants of long-term clinical outcome
94
Complete revascularisation and clinical outcomes of patients with multivessel diseaseBarbato E, Kornowski R, Wijns W, Unterseeh T, Teiger E, Joly P, Koning R, Lecoq G, Goicolea J, Wessely R, Babic R, Miloradovic V, Danzi G
95
Clinical risk stratification is a better determinant of long-term survival following multivessel PCI compared to anatomic risk stratification using the Syntax scoreLehmann R, Spyridopoulos I, Leistner D, Laskowski R, Baier G, Kremer J, Held L, De Rosa S, Schaechinger V, Zeiher A, Fichtlscherer S
PCI in STEMI patients: biochemical markers and clinical outcome
103
Clinical utility of biomarkers to predict major bleeding events after STEMI: a Horizons-AMI substudy with 3-year follow-upMehran R, Claessen B, Stone G, Witzenbichler B, Brodie B, Ruzyllo W, Zmudka K, Giulio G, Wohrle J, Huber K, Kochman J, Apostolidou I, Syros G, Leon S, Dangas G
104
C-reactive protein as a predictor of major adverse cardiovascular events in primary PCIRathod K, Jones D, Guttmann O, Rathod V, McGill L, May S, Sammut E, Graham A, Jain A, Mathur A, Knight C, Wragg A
PCI outcomes in specific patient subsets
109
Clinical and angiographic outcomes following PCI with DES in patients of chronic kidney diseaseTakimura H, Muramatsu T, Tsukahara R, Itou Y, Sakai T, Ishimori H, Hirano K, Nakano M, Yamawaki M, Sasaki S, Araki M, Sakamoto Y, Komatsu I, Takama T
110
The increasing cohort of patients older than 85 years: challenges for interventional cardiologistsCabanelas N, Gonçalves L, Soares F, Teixeira R, Faria H, Calisto J, Matos V, Viegas R, Silva C, Queiróz M, Providência L
111
The impact of anemia on long-term clinical outcome in patients undergoing PCIPilgrim T, Vetterli F, Räber L, Binder R, Wenaweser P, Moschovitis A, Khattab A, Büllesfeld L, Vogel R, Seiler C, Meier B, Windecker S
Primary PCI in STEMI patients with left main or multivessel occlusion
Primary PCI in STEMI patients: where is the challenge?
120
PCI and acute myocardial infarction: temporal changes in presentation, management and in-hospital mortalityJansen K, Jamart J, Boyazis P, Chenu P, Dangoisse V, Desonniaux C, Domange J, Guedes A, Mitri K, Morandini E, Randour C, Schroeder E
123
Early hospital discharge at 48 hours following primary PCI for myocardial infarction is both safe and feasibleSammut E, Jones D, Behar J, Rathod K, Graham A, Jain A, Knight C, Mohiddin S, Mathur A, Wragg A, Smith E
124
Comparative analysis of DES vs. bare metal stents for the treatment of STEMI- acute and mid-term outcomesEsteves V, Costa J, Costa R, Siqueira D, Abizaid A, Barbosa R, Moreira A, Cano M, Staico R, Maldonado G, Feres F, Sousa A, Sousa E
Registries of new generation of bare metal stents
127
Coronary angioplasty with bare metal stents: are there any differences?Costa F, Teles R, Gonçalves P, Raposo L, Calé R, Carvalho S, Cardoso G, Brito J, Leal S, Baptista J, Palos J, Almeida M, Mendes M
Risk of stent thrombosis and new generation DES
132
Thrombosis in real practice with second generation DES in special settings: myocardial infarction and left main coronary artery - results from the ESTROFA-2 Spanish registryDe La Torre Hernandez J, Alfonso F, Gimeno F, Diarte J, Lopez Palop R, Perez De Prado A, Fernandez-Guerrero J, Moreu J, Melgares R, Vazquez J, Rincon A, Cascon J, Serra A, Lozano I, Trillo R, Jimenez Mazuecos J, Garcia Del Blanco B, Pinar E, Sánchez-Recalde A, Rumoroso J-R, Hernandez F, Bosa F, Hernandez J, Larman M, Sanchis J, Rivero F, Diaz J, Elizaga J, Cascon M, Botas J, Gomez Jaume A, Salvatella N, Baz J, Bullones J
133
Biodegradable polymers, dual antiplatelet therapy and very late stent thrombosis: review of Nobori 2 studyMorice M-C, Wijns W, Neskovic A, Goicolea F, Iñiguez A, Koning R, Koolen J, Lecoq G, Ostojic M, Teiger E, Unterseeh T, Nedeljkovic M, Danzi G
135
Safety of dual antiplatelet therapy interruption after Resolute stent implantation: an Italian multicentre observational evaluationTommasino A, Burzotta F, Lioy E, Romagnoli E, Ielasi A, Latib A, De Vita M, Ausiello A, Missiroli B, Arena M, Benedetto S, Colombo A
Secondary prevention after PCI: evidence for plaque regression
143
Three-year clinical outcomes of the OLIVUS (impact of olmesartan on progression of coronary atherosclerosis; evaluation by intravascular ultrasound) trialHirohata A, Yamamoto K, Hirose E, Ohara M, Senoh K, Imai Y, Iino Y, Kobayashi Y, Takafuji H, Sano F, Nosaka K, Ohe T
Which DES for diabetics?
147
Clinical outcomes in diabetic and non-diabetic patients treated with Endeavor Resolute Zotarolimus eluting-stent: a multicentre Italian observational studyIelasi A, Latib A, Lioy E, Romagnoli E, Tommasino A, Burzotta F, De Vita M, My L, Missiroli B, Arena M, Della Rovere F, Trani C, Colombo A
148
Two-year clinical outcomes of diabetic patients treated with a new generation DESWiemer M, Wijns W, Joly P, Kornowski R, Witherow F, Novo Garcia E, Apró D, Ates I, Hauptmann K-E, Kala P, Koning R, Danzi G
149
Treatment with the Resolute Zotarolimus-eluting stent in subjects with diabetes mellitus: pooled analysis from the Resolute clinical programmeMauri L, Leon M, Yeung A, Meredith I, Serruys PW, Windecker S, Belardi J, Neumann F, Widimsky P, Saito S, Massaro J, Fajadet J, Wijns W, Silber S
Randomised clinical trials - Update
154
Pooled analysis of the Resolute programme clinical safety resultsMauri L, Leon M, Yeung A, Meredith I, Serruys PW, Silber S, Belardi J, Neumann F-J, Widimsky P, Saito S, Massaro J, Fajadet J, Wijns W, Windecker S
156
Two-year reports of efficacy and safety end points from the randomised, multicentre and controlled Eucatax trialRodriguez-Granillo A, Mieres J, Fernandez-Pereira C, Delacasa A, Vigo C, Risau G, Bernardi V, Bettinoti M, Santaera O, Rodríguez-Granillo G, Antoniucci D, Palacios I, Rodríguez A
157
The platinum small vessel trial: evaluation of the novel thin-strut platinum-chromium promus element small vessel everolimus-eluting stentMeredith I, Teirstein P, Stone G, Mann T, Rabinowitz A, Lee T, Kereiakes D, Carrié D, Cannon L, Allocco D, Dawkins K
Advances in cell-based regenerative therapy post-STEMI
Bioabsorbable scaffold: animal and human observations
169
Angiographic geometric changes of the lumen vessel wall after bioresorbable vascular scaffolds and metallic platform stents at one-year follow-upGomez-Lara J, Brugaletta S, Farooq V, van Geuns R-J, de Bruyne B, Windecker S, McClean D, Thuesen L, Dudek D, Koolen J, Whitbourn R, Smits P, Chevalier B, Morel M-A, Dorange C, Veldhof S, Rapoza R, García-García H, Ormiston J
170
Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffoldGutiérrez-Chico J-L, Radu M, Diletti R, Sheehy A, Kossuth M, Oberhausern J, Glauser T, Harrington J, Rapoza R, Onuma Y, Serruys PW
Innovations in catheter and stent design
174
Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol VShield device for the treatment of intravascular ultrasound and optical coherence tomography-derived thin cap fibroatheromas (TCFAS) in native coronary arteriesWykrzykowska J, Diletti R, Gutiérrez-Chico J-L, van Geuns R-J, van der Giessen WJ, Ramcharitar S, Duckers E, Schultz C, de Feyter P, Van Der Ent M, Regar E, de Jaegere P, García-García H, Gonzalo N, Ligthart J, Serruys PW
Microvascular function after PCI
New stent technology and first-in-man
185
Preliminary results of the multicentric, double-blinded, randomised, Vestasync II trialCosta Jr J, Abizaid A, Feres F, Oliveira B, Perim M, Costa R, Siqueira D, Staico R, Tanajura L
186
One-year follow-up of the ProNOVA XR polymer free Sirolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the EURONOVA studyLegutko J, Heba G, Rzeszutko L, Zasada W, Jakala J, Dragan J, Klecha A, Giszterowicz D, Dobrowolski W, Partyka L, Dudek D
188
De novo coronary lesions treated with the novel polymer-free Biolimus-A9 coated stents: four- and twelve-month angiographic results from the prospective, randomised, multicentre BIOFREEDOM clinical trialCosta R, Abizaid A, Mehran R, Magalhaes M, Gambone L, Parise H, Schuler G, Hauptmann K-E, Schofer J, Grube E
New stents: bench testing
190
Conformability of the Nevo; Sirolimus-eluting coronary stent system in comparison with the Xience; Everolimus-eluting coronary stent system: results from a bench top study and an angiographic assessment from the Nevo II clinical trialGomez-Lara J, García-García H, Windecker S, Sabate M, Pieters M, Jew V, Schroeder V, Grishaber R, Ryder K, Stoll H, Serruys PW
Optical coherence tomography: revealing the results of PCI with DES and bioresorbable stents
194
Vascular healing response five years after implantation of first generation DES: the SIRTAX LATE optical coherence studyRäber L, García-García H, Baumgartner S, Kalesan B, Justiz J, Pilgrim T, Wenaweser P, Moschovitis A, Vogel R, Meier B, Jüni P, Serruys PW, Windecker S
196
Tissue coverage of a hydrophilic polymer-coated Zotarolimus-eluting stent vs. a fluoropolymer-coated Everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE all-comers trialGutiérrez-Chico J-L, van Geuns R-J, Regar E, van der Giessen WJ, Kelbæk H, Saunamäki K, Escaned-Barbosa J, Gonzalo N, Di Mario C, Borgia F, Nüesch E, García-García H, Silber S, Windecker S, Serruys PW
197
Long-term tissue coverage of a bioresorbable polylactide polymer-coated Biolimus-eluting stent: comparative sequential assessment with optical coherence tomography till complete resorption of the polymerGutiérrez-Chico J-L, Jüni P, García-García H, Regar E, Borgia F, van der Giessen WJ, Davis S, van Geuns R-J, Secco G, Meis S, Windecker S, Serruys PW, Di Mario C
Primary PCI in STEMI patients: new techniques
199
Drug-eluting balloon in acute myocardial infarction (DEBAMI) trialWong A, Lim V, Leow K, Lim S, Wong P, Chiam P, Tan J, Chia S, Chan C, Lingamanaicker J, Koh T-H
New stents: pre-clinical studies
3D coronary angiography and novel imaging techniques: implications for PCI
Accuracy of IVUS and optical coherence tomography to quantify coronary artery disease and evaluate PCI results
222
Absence of a relation between plaque composition in proximal non-target coronary vessels vs. cardiovascular event risk: a pilot study with volumetric radiofrequency-based intravascular ultrasoundHuisman J, Hartmann M, Mattern E, Mintz G, Van Houwelingen G, Stoel M, De Man F, Linssen G, Pos B, Van Der Lee C, Van Der Palen J, von Birgelen C
223
Impact of anemia on coronary plaque components: virtual histology-intravascular ultrasound analysisHong Y, Jeong M, Choi Y, Hwang S, Ko J, Lee M, Park K, Sim D, Kim J, Ahn Y, Cho JG, Park J, Kang J
Arterial access: use of closure devices
226
Randomised comparison of manual compression and use of Femoseal vascular closure device for closure after femoral artery access coronary angiography. The CLOSure dEvices Used in everyday Practice (CLOSE-UP) studyHolm N, Sindberg B, Schou M, Maeng M, Kaltoft A, Bøttcher M, Krusell L, Thuesen L, Terkelsen C, Christiansen EH, Bøtker H, Kristensen S, Lassen J
CTO recanalisation: technical aspects
230
Impact of calcium distribution for successful revascularisation of coronary chronic total occlusion: assessment from computed tomography coronary angiographyAraki M, Muramatsu T, Tsukahara R, Ito Y, Ishimori H, Hirano K, Nakano M, Yamawaki M, Sasaki S, Takimura H, Sakamoto Y, Komatsu I, Takama T
231
Impact of novel 0.010-inch Athlete Wizard guidewire use on successful recanalisation of coronary chronic total occlusions via antegrade access in a large single-centre registryKido A, Ueda H, Natsuyama K, Asawa K, Yoshida N, Sasaki Y, Yamaguchi K, Kuga Y, Yamawaki M, Ueda K, Nishida Y
233
Safety of retrograde recanalisations to coronary chronic total occlusion via transseptal pathways with use of a novel metal-catheterTakimura H, Muramatsu T, Tsukahara R, Ito Y, Sakai T, Ishimori H, Hirano K, Nakano M, Yamawaki M, Sasaki S, Araki M, Sakamoto Y, Komatsu I, Takama T
234
Well developed collateral circulation is associated with better vascular function distal to recanalised coronary chronic total occlusionsBrugaletta S, Martin-Yuste V, Padrÿ T, Alvarez-Contreras L, Gomez-Lara J, García-García H, Cola C, Liuzzo G, Masotti M, Crea F, Badimon L, Serruys PW, Sabate M
Dedicated stents for bifurcation lesion PCI
237
Complex coronary bifurcation lesions treated with the novel polymer-free dedicated bifurcation paclitaxel-eluting stent (Nile pax): clinical and angiographic clinical results of the prospective, multicentre bipax clinical trialCosta R, Abizaid A, Abizaid An, Garcia B, Berland J, Petrov I, Brenot P, Serruys PW, Royer T, Rubino P, Lasiak M, Fajadet J
238
The dedicated drug-eluting Bifurcation Optimisation Stent System (BiOSS) Registry first-in-human resultsGil R, Vassilev D, Michalek A, Kulawik T, Kern A, Dobrzycki S, Ochala A, Formuszewicz R, Kardaszewicz P, Wójcik J, Lesiak M
240
Final results from the AnGIoSculpt® MuLti-Center Coronary BIfurcation STudY- AGILITY TrialMoses J, Metzger C, Liberman H, O’ Shaughnessy C, Douglas J, Turco M, Resar J, Quesada R, Dave R, Gershony G, Leon M
DES and bioactive stents for STEMI
244
Comparison of the efficacy and safety of Everolimus-, Sirolimus-, and Zotarolimus-eluting stents in patients with STEMIJang J, Jo Y, Jin H, Seo J, Yang T, Kim D, Kim D, Kim D, Kim D
246
DES with biodegradable polymers in acute myocardial infarctionFath-Ordoubadi F, Ostojic M, Perisic Z, Koolen J, Mavronasiou E, Richardt G, Roguin A, Sagic D, Stabile A, Strupp G, Stojkovic S, Stankovic G, Orlic D, Danzi G
247
Comparison between Zotarolimus-eluting stents and first generation DES in the treatment of patients with acute STEMIPark K, Lim W, Kang S, Song Y, Hahn J-Y, Kang H, Choi Y, Youn T, Koo B-K, Chae I, Gwon H, Choi D, Kim H
DES in special lesions and patient subsets
250
Effect of PCI with Paclitaxel-eluting stent in hemodialysis patients: comparison with Sirolimus-eluting stentTakimura H, Muramatsu T, Tsukahara R, Ito Y, Sakai T, Ishimori H, Hirano K, Nakano M, Yamawaki M, Sasaki S, Araki M, Sakamoto Y, Komatsu I, Takama T
251
Clinical outcomes after PCI with DES in patients with chronic kidney diseaseTakimura H, Muramatsu T, Tsukahara R, Ito Y, Sakai T, Ishimori H, Hirano K, Nakano M, Yamawaki M, Sasaki S, Araki M, Sakamoto Y, Komatsu I, Takama T
252
Small coronary vessels stenting in the DES era: very long-term (>3 years) clinical outcomesQuadri G, D’ascenzo F, Longo G, Bollati M, Gonella A, Di Cuia M, Omedè P, Moretti C, Sciuto F, Biondi-Zoccai G, Gaita F, Sheiban I
253
DES improve long-term outcomes compared to bare metal stents (BMS) for the treatment of isolated proximal left anterior descending (LAD) coronary arteryGuttmann O, Jones D, Rathod K, Ludman A, Pain T, Akhtar M, Jain A, Knight C, Mathur A, Amersey R, Wragg A
255
Comparison of Everolimus- vs. first generation DES In left main coronary artery lesions: the HSR-EMO experienceIelasi A, Chieffo A, Latib A, Gullace M, Mussardo M, Davidavicius G, Bertoldi L, Takagi K, Shannon J, Godino C, Carlino M, Montorfano M, Colombo A
DES or protection devices in saphenous vein graft PCI
262
Two-year clinical outcomes after treatment of saphenous vein graft with a new generation DESWessely R, Strupp G, Schwacke H, Marzocchi A, Nguyen N, Kala P, Karavolias G, Vrolix M, Lanzer P, Jagic N, Wiemer M, Miloradovic V, Beleslin B, Stojkovic S, Danzi G
263
Comparative analysis of a distal protection system and the new stent M-Guard for the treatment of complex lesions in saphenous vein graftsEsteves V, Costa J, Abizaid A, Costa R, Maia F, Barbosa R, Siqueira D, Mattos L, Staico R, Esteves C, Feres F, Sousa A, Sousa E
264
Intravascular ultrasound predictors of no-reflow after percutaneous saphenous vein graft intervention with distal protection devicesHong Y, Mintz G, Jeong M, Ahn Y, Kim S, Lee S, Kim S, Pichard A, Satler L, Waksman R, Kent K, Suddath W, Hwang S, Ko J, Lee M, Park K, Sim D, Kim J, Cho J, Park J, Kang J, Weissman N
Drug-eluting balloons
267
Comparison of bare metal and DES restenosis after treatment with a novel drug-eluting balloon - a subgroup analysis of the PEPPER first-in-man trialToelg R, Richardt G, Wiemer M, Schneider H, Lesiak M, Naber C, Hoffman E, Jørgensen E, Kubica J, Dietz U, Hehrlein C
268
Trend towards lower target lesion revascularisation and measure adverse cardiovascular event rates in patients treated with drug-eluting balloon compared with DESUnverdorben M, Degenhardt R, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner G, Antoni D, Kleber F, Bocksch W, Leschke M, Ackermann H, Boxberger M, Scheller B
269
Treatment of the coronary in-stent restenoses with Paclitaxel coated balloon cathetersManukov I, Tonev G, Litcanov O, Tcvetkovski T, Deenichina I, Marinov M, Goranov G, Aliman O, Manukov H, Milcheva E, Sheremetov D
271
Predictors of recurrent restenosis after Paclitaxel-eluting balloon for the treatment of DES restenosisHabara S, Mitsudo K, Kadota K, Goto T, Oka N, Fuku Y, Hosogi S, Tanaka H, Tada T, Shigemoto Y, Hasegawa D, Otsuru S, Saito N
Fractional flow reserve: additional or complementary to coronary invasive imaging?
272
Comparison of different strategies to obtain maximal hyperaemia in the assessment of fractional flow reserve for intermediate coronary stenosis: intravenous adenosine vs. incremental dosages of intracoronary adenosine vs. intracoronary nitroprusside (Nitroprussiato vs. Adenosina nelle Stenosi Coronariche Intermedie, the NASCI study)Leone A, De Caterina A, Porto I, Niccoli G, Burzotta F, Trani C, Aurelio A, Basile E, Mazzari M, Mongiardo R, Rebuzzi A, Crea F
274
Non-invasive computation of fractional flow reserve in patients with multivessel coronary artery diseaseErglis A, Jegere S, Runkule Z, Zvaigzne L, Sondore D, Kumsars I, Narbute I, Dombrovskis A, Trusinskis K, Mintale I, Latkovskis G
277
Defer PCI on fractional flow reserve basis: 4-year follow-up in single-centre retrospective studyUguccioni S, Uguccioni L, Marinucci L, Parisi R, Canestrari E, Battistini A, Del Bene R, Fattori S, Ferretti C, Maffei K, Mattioli M, Mazzilli L, Montesi P, Ricciardelli P
Imaging DES results: optical coherence tomography and other techniques
280
Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap segments in DES 9-13 months after implantation: in vivo-assessment with optical coherence tomographyGutiérrez-Chico J-L, Räber L, Regar E, Okamura T, Di Mario C, Windecker S, Valgimigli M, Sabate M, von Birgelen C, Van Es G-A, Serruys PW
282
Does a last generation thin-strut DES produce a better vascular response compared with a first generation thick-strut DES?Ikejima H, Sirbu V, Bezerra H, Musumeci G, Lortkipanidze N, Fiocca L, Satoko T, Vassileva A, Matiashvili A, Valsecchi O, Costa M, Guagliumi G
284
Angioscopic assessment of arterial repair of biodegradable polymer-coated Biolimus A9-eluting stent: comparison with durable polymer-coated Sirolimus-eluting stent in patientsAwata M, Fusako S, Ishihara T, Tetsuya W, Fujita M, Iida O, Okamoto S, Tanaka N, Dohi T, Mishima T, Mizugami Y, Nanto K, Ishida Y, Nanto S, Uematsu M, Nagata S
Impact of lesion morphology and deployment technique on DES outcomes
287
Very small vessels (<2.5 mm) treated with Nobori DES: two-year clinical outcomesCarrié D, Karavolias G, Wiemer M, Santoso T, Marzocchi A, Laanmets P, West N, Serra A, Monsegu J, Santarelli A, Birkemeyer R, Babic R, Danzi G
288
Charlson comorbidity index as a predictor of clinical outcomes after PCIUrban P, Aptecar E, Darremont O, Ostojic M, Descaves C, Filippone V, Hauptmann K-E, Lombardi M, Quan Huan D, Tastan A, Vuilliomenet A, Zhang X, Sagic D, Danzi G
290
Clinical impact of coronary drug eluting stents overlapLim V, Ostojic M, Tresukosol D, Wiemer M, West N, Monsegu J, Barbato E, Unterseeh T, McKenzie D, Perisic Z, Danzi G
Incidence and treatment of in-stent restenosis
291
In-stent restenosis is not simply a benign clinical entity as it presents as acute coronary syndromes in 40% of casesRathod K, Jones D, Rathod V, Akhtar M, Guttmann O, Pain T, Behar J, Jain A, Mathur A, Knight C, Wragg A
292
Repeated DES vs. balloon angioplasty for management of DES associated restenosis in de novo and in-stent restenosis lesionsAbdelmegid M, Kato M, Ando K, Domei T, Yamaji K, Shirai S, Arita T, Soga Y, Kondo K, Sakai K, Goya M, Yokoi H, Nosaka H, Iwabuchi M, Nobuyoshi M
294
Long-term clinical outcome after treatment of restenotic lesions with a new generation DESWest N, Sagic D, Ostojic M, Jagic N, Neskovic A, Mavronasiou E, Richardt G, Roguin A, Iñiguez A, Stabile A, Strupp G, Babic R, Milosavljevic B, Topic D, Danzi G
295
Comparison of restenosis patterns in 1st and 2nd generation DESSakamoto Y, Muramatsu T, Tsukahara R, Ito Y, Ishimori H, Hirano K, Nakano M, Yamawaki M, Araki M, Takimura H, Komatsu I, Takama T
296
Stent recoil varies with DES type and influences long-term luminal loss. A comparative longitudinal study using a novel methodology for in vivo assessment of stent recoilEscaned J, Sandoval J, Arellano E, Colmenarez H, Gonzalo N, Jimenez P, Alfonso F, Fernandez Ortiz A, Ibanez B, Garcia E, Banuelos C, Hernandez R, Macaya C
297
Intravascular ultrasound findings at in-stent restenosis segment of overlapped drug-eluting stentSakamoto Y, Muramatsu T, Tsukahara R, Ito Y, Ishimori H, Hirano K, Nakano M, Yamawaki M, Sasaki S, Araki M, Takimura H, Komatsu I, Takama T
IVUS in acute coronary syndrome: how lesion morphology may impact on outcome
300
Reproducibility of volumetric virtual histology intravascular ultrasound analyses in coronary lesions prior to stenting: an European multicentre study on between-centre reproducibilityHuisman J, Egede R, Rdzanek A, Böse D, Erbel R, Kochman J, Okkels Jensen L, Van Der Palen J, Hartmann M, Mintz G, von Birgelen C
302
VH-intravascular ultrasound findings predict major adverse cardiovascular events, post-PCI myocardial infarction and troponin rise: the VIVA (VH-intravascular ultrasound in vulnerable atherosclerosis) studyCalvert P, Obaid D, O’ Sullivan M, Shapiro L, McNab D, Densem C, Schofield P, Braganza D, Clarke S, Ray K, West N, Bennett M
Novel imaging techniques for assessment of PCI
304
Usefulness of a trans-stent fractional flow reserve gradient for assessing the results of DES implantationTahk S, Lim H, Yang H, Yoon M, Jin X, Joe D, Choi S, Choi B, Park J, Hwang G, Shin J
305
Comparison of neointimal coverage between zotarolimus-eluting stent and everolimus-eluting stent using optical coherence tomographyKim J, Kim B, Ko Y, Choi D, Hong M, Cho Y, Nam C, Seung-Ho H, Choi J, Song Y, Hahn J-Y, Choi S, Kwon H, Jang Y
306
Early detection of stent tissue coverage and apposition after primary angioplasty: an optical coherence tomographic study of chromium cobaltum and first generation DESPrati F, Stazi F, Dutary J, La Manna A, Di Giorgio A, Pawlosky T, Gonzalo N, Ramazzotti V, Di Salvo M-E, Imola F, Tamburino C, Alfonso F
308
A six-month analysis of quantitative echogenicity of the second generation everolimus-eluting bioresorbable vascular scaffold in relationship with baseline greyscale intravascular ultrasound morphology of the scaffolded plaqueBrugaletta S, Serruys PW, Ormiston J, Gomez-Lara J, Farooq V, van Geuns R-J, de Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn R, Veldhof S, Miquel-Hebert K, Rapoza R, van Domburg R, Sihan K, de Winter S, García-García H, Bruining N
Optical coherence tomography: to assess the results of PCI
312
The use of 3-dimensional reconstruction of optical frequency domain imaging to improve our understanding of conventional PCI: the potential for clinical applicationFarooq V, Okamura T, Heo J, Gogas B, Gomez-Lara J, Magro M, Onuma Y, Brugaletta S, Radu M, García-García H, Serruys PW
313
Optical coherence tomography findings of plaque rupture occurred by balloon angioplastyIshimori H, Muramatsu T, Tsukahara R, Ito Y, Hirano K, Nakano M, Yamawaki M, Araki M, Sasaki S, Sakamoto Y, Takimura H, Komatsu I, Takama T
PCI for unprotected left main stenosis
PCI techniques for bifurcation lesions
323
Angiographic and intravascular ultrasound predictors of side branch failure during PCI with provisional side branch stenting approach in complex coronary bifurcation lesionsCosta R, Feres F, Staico R, Costa Jr J, Siqueira D, Abizaid A, Mattos L, Luiz F. T, Sousa A, Sousa J, Colombo A
Platelet reactivity in patient subsets
339
Clinical impact of short term discontinuation of dual antiplatelet therapy (DAPT) after drug eluting stent (DES) implantation for coronary artery diseaseSakamoto Y, Muramatsu T, Tsukahara R, Ito Y, Ishimori H, Hirano K, Nakano M, Yamawaki M, Sasaki S, Motoharu A, Takimura H, Komatsu I, Takama T
Primary PCI in STEMI: thrombus aspiration or filter devices
341
Predictors of short-term mortality in patients with STEMI undergoing primary percutaneous transluminal coronary angioplastyPyxaras S, Cinquetti M, Perkan A, Barbati G, Vitrella G, Santangelo S, Giannini F, Rakar S, DellaGrazia E, Salvi A, Sinagra G
343
Non-obstructive coronary disease leading to STEMI: assessment of residual stenosis after thrombus aspirationBrito J, Gonçalves P, Raposo L, Teles R, Calé R, Sousa P, Galvïo Santos P, Santos M, Batista J, Palos J, Sousa Almeida M, Mendes M
Radial or femoral access: revisiting an old dispute
353
Cost analysis and in hospital safety study on using transradial approach versus transfemoral approach in primary percutaneous coronary intervention for acute st segment elevation myocardial infarction patients in killip class 1 or 2: a single centre studyTan V, Wang W, Chow W, Ang S, Chow J, Ong S, Goh Y, Gan H, Tan K, Lim V, Jayaram L, Goh P, Tan C
Testing antiplatelet reactivity in daily practice
Transradial access: safety and complications
360
Safety of transradial approach in 10,676 consecutive percutaneous coronary proceduresBurzotta F, Trani C, Mazzari M, Mongiardo R, Porto I, Leone A, Niccoli G, Tommasino A, Tinelli G, Coluccia V, De Vita M, Brancati M, Mariani L, Schiavoni G, Crea F
361
Transradial coronary angiography: predictors of adversityCosta F, Gonçalves P, Sousa P, Brito J, Calé R, Santos M, Dores H, Galvïo Santos P, Raposo L, Teles R, Almeida M, Silva A, Mendes M
363
Management of access site vascular complications in patients undergoing transradial percutaneous coronary proceduresBurzotta F, Trani C, Mariani L, Tommasino A, Tinelli G, Brancati M, Coluccia V, Porto I, Leone A, Niccoli G, Mazzari M, Mongiardo R, Schiavoni G, Crea F
365
Transradial approach in patients with post-catheterisation occlusion of radial arteryTrani C, Burzotta F, Tommasino A, Leone A, Giammarinaro M, Brancati M, Talarico G, Porto I, Niccoli G, Mongiardo R, Mazzari M, Schiavoni G, Crea F
Transradial access: technical and procedural aspects
371
Radial approach for coronary chronic total occlusion lesions: acute, long-term results and impact of learning curveBurzotta F, Trani C, Tommasino A, Giammarinaro M, De Vita M, Di Noi P, Niccoli G, Porto I, Leone A, Mazzari M, Mongiardo R, Coluccia V, Schiavoni G, Crea F
Clinical outcome after TAVI: mid-term follow-up
375
Final one-year outcomes of >2,300 patients in the source of registry, using the Edwards Sapien bioprostesis for TAVI in EuropeThomas M, Schymik G, Mohr F, Fusaro M, Hendrik T, Hutter A, Himbert D, Rubino P, Baumgartner H, Lefèvre T, Schalij M, Wendler O
377
Outcomes Following TAVI with both Edwards SAPIEN and CoreValve devices in a single centre: the on-going Milan ExperienceGodino C, Montorfano M, Chieffo A, Maisano F, Latib A, Mussardo M, Cioni M, Taramasso M, Figini F, Franco L, Carlino M, Alfieri O, Colombo A
Conduction abnormalities after TAVI
384
Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve system in patients with aortic stenosisNuis R, Van Mieghem N, Schultz C, Tzikas A, Van Der Boon R, Maugenest A-M, Cheng J, Piazza N, van Domburg R, Serruys PW, de Jaegere P
386
Factors affecting need for permanent pacemaker insertion following CoreValve transcatheter aortic valve implantation - the UK CoreValve CollaborativeKhawaja M, Rajani R, Cook A, Khavandi A, Moynagh A, Chowdhary S, Spence M, Brown S, Khan S, Walker N, Trivedi U, Hutchinson N, De Belder A, Moat N, Blackman D, Levy R, Manoharan G, Roberts D, Khogali S, Khogali S, Brecker S, Baumbach A, Mullen M, Laborde J-C, Hildick-Smith D
Devices and imaging the results
Edge-to-edge mitral valve repair: clinical, hemodynamic and echocardiographic evaluation
393
Percutaneous mitral valve repair in high-risk patients - The Swiss experience after the first 100 patientsSürder D, Pedrazzini G, Moccetti T, Pasotti E, Faletra F, Erne P, Zuber M, Jamshidi P, Auf Der Maur C, Kaiser C, Jeger R, Hürlimann D, Gämperli O, Bettex D, Biaggi P, Grünenfelder J, Corti R
Percutaneous mitral valve intervention from balloon to replacement
PFO: clinical experience and new devices
Predictors of clinical outcome after TAVI
412
The impact of peripheral arterial disease on outcome after TAVI: results from the German TAVI registrySinning J-M, Grube E, Horack M, Ghanem A, Hammerstingl C, Gerckens U, Linke A, Zahn R, Eggebrecht H, Sievert H, Hambrecht R, Sack S, Hauptmann K-E, Richardt G, Figulla H, Senges J, Nickenig G, Werner N
Quality of life and neurocognitive function after TAVI
419
Durability of quality of life improvement in elderly patients after TAVIBarbanti M, Ussia G, Sarkar K, Cammalleri V, Mulè M, Immè S, Scarabelli M, Aruta P, Pistritto A, Del Campo G, Capodanno D, Tamburino D
Results of TAVI: evaluation by echocardiography
425
Serial echocardiographic follow-up of the CoreValve bioprosthesis: 1-year results of 400 patients from the Italian registryDe Carlo M, Fiorina C, Napodano M, Bedogni F, Klugmann S, Ussia G, Maisano F, Santoro G, Ettori F, Ramondo A, Petronio A
TAVI and coronary artery disease
429
Impact of coronary artery disease in elderly patients undergoing TAVI: insight the Italian CoreValve registryBarbanti M, Ussia G, Petronio A, Tarantini G, Ramondo A, Napodano M, Ettori F, Santoro G, Bedogni F, Maisano F, Fiorina C, De Carlo M, Klugmann S, Poli A, Tamburino C
430
Does previous coronary bypass surgery increase the risk for patients undergoing TAVI?Wendler O, Schroefel H, Rastan A, Fusari M, Franzen O, Lange R, Nataf P, Sorropago G, Kaleschke G, Romano M, Deweger A, Thomas M
432
The effects of pre-existing significant coronary artery disease upon outcome after TAVI using the Edwards bioprosthesisKhawaja M, Haran H, Nadra I, Wilson K, Clack L, Macgillivray K, Hancock J, Young C, Bapat V, Thomas M, Redwood S
433
The impact of coronary artery disease on clinical outcomes in patients undergoing TAVIPilgrim T, Windecker S, Stortecky S, Huber C, Erdös G, Kadner A, Meuli F, Khattab A, Meier B, Carrel T, Wenaweser P
TAVI: clinical outcome in various patient subsets
438
TAVI in low-flow low-gradient aortic stenosis: early experienceFiorina C, Coletti G, D’aloia A, Chizzola G, Curello S, Maffeo D, Chiari E, Seresini G, Bellandi F, Tanghetti E, Manzato A, Ettori F
TAVI: clinical outcomes and complications
443
Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatationTakagi K, Latib A, Al-Lamee R, Ielasi A, Mussardo M, Montorfano M, Maisano F, Godino C, Shannon J, Davidavicius G, Grimaldi A, La Canna G, Cioni M, Franco A, Carlino M, Chieffo A, Alfieri O, Colombo A
Left atrial appendage closure from single centre experience to large randomised trials
Management of arterial access in TAVI
455
1-year results of the subclavian access for TAVI with the CoreValve bioprosthesis in 132 consecutive patientsDe Carlo M, Bedogni F, Maisano F, Ettori F, Klugmann S, Poli A, Marzocchi A, Santoro G, Napodano M, Ussia G, Petronio A
457
Transfemoral aortic valve implantation: new criteria to predict vascular complicationsHayashida K, Lefèvre T, Chevalier B, Hovasse T, Romano M, Garot P, Mylotte D, Uribe J, Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Morice M-C
Valve in valve: TAVI for treatment of degenerative bioprosthesis
460
Transcatheter valve-in-valve implantation using CoreValve Revalving System in high risk patients with failed aortic bioprosthesis: a multi-centre experienceLaudisa M-L, Testa L, Brambilla N, Ussia G, Petronio A, Ramondo A, Ettori F, Santoro G, Klugman S, De Marco E, Pizzocri S, Bedogni F
461
Valve-in-valve procedure with the Edwards transcatheter heart valve to treat bioprosthetic valve degeneration in high-risk surgical patientsIelasi A, Latib A, Mussardo M, Montorfano M, Maisano F, Chieffo A, Godino C, Davidavicius G, Cioni M, Taramasso M, Carlino M, Alfieri O, Colombo A
Valve malpositioning and procedural refinement during TAVI procedures
467
Correction of prosthesis malpostitioning during TAVI with CoreValveVavuranakis M, Vrachatis D, Moldovan C, Kariori M, Toutouzas K, Sanidas E, Brilli S, Chrysochoou C, Papaioannou T, Tzamalis P, Katsarou O, Stefanadis C
468
The valve-in-valve technique for treatment of aortic bioprosthesis malposition: an analysis of incidence and 1-year clinical outcomes from the Italian CoreValve registryBarbanti M, Ussia G, Napodano M, Ramondo A, Petronio A, Ettori F, Santoro G, Bedogni F, Klugmsnn S, Maisano F, Tarantini G, De Carlo M, Fiorina C, Tamburino C
471
A high dose of adenosine to induce transient asystole for valvuloplasty in patients undergoing TAVI: is it a valid alternative to rapid pacing? A prospective pilot studyDavidavicius G, Chieffo A, Arioli F, Ielasi A, Shannon J, Mussardo M, Takagi K, Maisano F, Montorfano M, Godino C, Latib A, Colombo A
Beyond the borders: new devices and indications for endovascular treatment
480
Do all the patients taking antiplatelet agents undergoing routine gastroscopic mucosal biopsy should stop these agents one week before? Implications from gastric mucosal bleeding time and antiplatelets discontinuation study (BLISS study)Yu H, Ahn B, Lee K, Cho J, Kim J, Choi S, Shin S, Kim H, Park S, Lee N, Lee M
Cardiovascular impact of non coronary atherosclerosis
Carotid artery stenting patient and lesion characterisation
488
Treatment stratification of carotid artery stenosis: novel duplex-sonographic velocity cut-off valuesMacharzina R, Fan N, Böhme T, Moske-Eick O, Weber J, Vach W, Rastan A, Beschorner U, Flügel P, Neumann F-J, Zeller T
489
Comparison of angiography and computer tomography-angiography with B-flow ultrasound in carotid stenoses: improved pre-interventional evaluation of carotid stenoses by B-flow ultrasoundMacharzina R, Böhme T, Fan N, Witzel C, Rastan A, Moske-Eick O, Flügel P, Beschorner U, Bürgelin K, Neumann F-J, Weber J, Zeller T
Endovascular management of lower limb ischaemia
498
Bail-out stenting for treatment of below the knee arterial disease: acute results and one-year clinical follow-up. A single centre experienceCioppa A, Salemme L, Stabile E, Sarno G, Ambrosini V, Popusoi G, Tesorio T, Sorropago G, Cota L, Biamino G, Rubino P
Endovascular treatment of thoracic and abdominal aorta
Latest on femoro-popliteal interventions
510
Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive proceduresBonvini R, Rastan A, Sixt S, Noory E, Schwarz T, Frank U, Roffi M, Dorsaz P, Schwarzwaelder U, Buergelin K, Macharzina R, Zeller T
Stenting for complex lesions above and below the inguinal ligament
516
Mid-term outcome of endovascular treatment with primary self expandable stent placement for chronic total occlusion of iliac arteryAraki M, Muramatsu T, Tsukahara R, Ito Y, Ishimori H, Hirano K, Nakano M, Yamawaki M, Sasaki S, Takimura H, Sakamoto Y, Komatsu I, Takama T
Latest aspects on carotid artery stenting
523
Early and long-term outcomes following combined percutaneous revascularisation in patients with carotid and coronary artery stenosesTomai F, Pesarini G, Castriota F, Reimers B, De Luca L, De Persio G, Pacchioni A, Spartê D, Aurigemma C, Spagnolo B, Cremonesi A, Ribichini F
Cross-talk between PCI and surgery
